FHIR is increasingly being adopted in cancer research to streamline data collection and analysis. Key implementations include:
Clinical Trials: FHIR facilitates the collection of standardized data across multiple study sites, enhancing the quality and consistency of research data. Genomics: By integrating genetic and molecular data, FHIR supports research into the genetic underpinnings of cancer and the development of targeted therapies. Real-World Evidence: FHIR enables the collection and analysis of real-world data from EHRs, offering insights into the effectiveness of cancer treatments outside of controlled clinical trials.
